Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral α-Amylase Enzyme Replacement for Diabetic Polyneuropathy
NCT07148804Phase 2Completed
- Sponsor
- Helwan University
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules, Replacement Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing Fermented Deglycyrrhizinated Licorice with Placebo (2 arms). Primary endpoint: Sensory Nerve Conduction Velocity at 6 months. Started Jan 2023; status: completed.
02
Drugs
fermented deglycyrrhizinated licorice
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07148804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07148804.